ChemLifeIntelCHEMICAL & LIFE SCIENCES INTELLIGENCE
Access
ChemLifeIntel/Companies/Keystone Industries

Keystone Industries

HIGH RISKHQ: — · Private · Founded —
LISTINGPrivateFOUNDED0
FOCUS THERAPY AREAS
Manufacturer
COMPANY INTELLIGENCE SNAPSHOTlive
2
Manufacturing Sites
2
Intelligence Briefs
0
Active Regulatory Actions
US
HQ Country
ON WATCH0 open regulatory items · compliance footprint stable across 2 sites
View regulatory detail

INTELLIGENCE

Showing 2 of 2 briefs on Keystone Industries
REGULATORY INTELLIGENCE·Recall

Keystone Industries Initiates Class II Recall for Gelato Benzocaine Gel Due to CGMP Deviations

Keystone Industries has executed a Class II recall (D-0137-2025) for its Gelato Benzocaine 20% Topical Gel Anesthetic. This action stems from critical CGMP deviations where a quality-rejected batch was inadvertently released and shipped. This event underscores significant supply chain risks for distributors and healthcare providers across the USA, Canada, and Latin American markets.

90-Day Activity
Keystone IndustriesGELATO TOPICAL ANESTHETIC
PSPriya Subramaniam· Intelligence Analyst
2024-12-25
REGULATORY INTELLIGENCE·Recall

Keystone Industries' Benzocaine Gel Recall: CGMP Violations Impact Global Dental Supply Chains

Keystone Industries initiated a Class II recall (D-0145-2025) for SAFCO SENSICAINE ULTRA TOPICAL ANESTHETIC GEL due to critical CGMP deviations. The Quality Unit rejected bulk product from a scratched mixing vessel, yet it was inadvertently released and distributed across the USA, Canada, and Latin America. This event highlights significant supply chain integrity risks for procurement and regulatory teams.

90-Day Activity
Keystone IndustriesSAFCO SENSICAINE ULTRA TOPICAL ANESTHETIC GELHSN Benzocaine
PSPriya Subramaniam· Intelligence Analyst
2024-12-25 Trending signal